Chemed
0
Funds holding %
of 7,398 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
322% more call options, than puts
Call options by funds: $14.3M | Put options by funds: $3.39M
15% more first-time investments, than exits
New positions opened: 63 | Existing positions closed: 55
0% more funds holding
Funds holding: 523 [Q3] → 525 (+2) [Q4]
1.26% less ownership
Funds ownership: 93.96% [Q3] → 92.7% (-1.26%) [Q4]
14% less capital invested
Capital invested by funds: $8.5B [Q3] → $7.35B (-$1.15B) [Q4]
24% less repeat investments, than reductions
Existing positions increased: 162 | Existing positions reduced: 213
60% less funds holding in top 10
Funds holding in top 10: 5 [Q3] → 2 (-3) [Q4]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
Low target
$667
8%
upside
Avg. target
$667
8%
upside
High target
$667
8%
upside
1 analyst rating
1 positive
100%
0 neutral
0%
0 negative
0%
RBC Capital Ben Hendrix 41% 1-year accuracy 27 / 66 met price target | 8%upside $667 | Outperform Maintained | 14 Mar 2025 |
Financial journalist opinion
Based on 3 articles about CHE published over the past 30 days
Neutral
Business Wire
2 days ago
Chemed To Report First-Quarter 2025 Earnings April 23, Related Conference Call To Be Held On April 24
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the first quarter ended March 31, 2025, on Wednesday, April 23, 2025, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Thursday, April 24, 2025, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call through.
Positive
Zacks Investment Research
6 days ago
Why Is Chemed (CHE) Up 4.5% Since Last Earnings Report?
Chemed (CHE) reported earnings 30 days ago. What's next for the stock?
Positive
Zacks Investment Research
2 weeks ago
OPCH vs. CHE: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Outpatient and Home Healthcare stocks have likely encountered both Option Care (OPCH) and Chemed (CHE). But which of these two stocks presents investors with the better value opportunity right now?
Positive
Zacks Investment Research
4 weeks ago
OPCH or CHE: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Option Care (OPCH) and Chemed (CHE). But which of these two stocks is more attractive to value investors?
Neutral
Business Wire
1 month ago
Chemed Corporation to Present at the Oppenheimer 35th Annual Healthcare Conference
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the Oppenheimer 35th Annual Healthcare Conference on Monday, March 17, 2025, at approximately 9:20 a.m. (ET). The virtual presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the live presentation and will be acce.
Neutral
Seeking Alpha
1 month ago
Chemtrade Logistics Income Fund (CGIFF) Q4 2024 Earnings Call Transcript
Chemtrade Logistics Income Fund (OTC:CGIFF) Q4 2024 Earnings Conference Call February 28, 2025 10:00 AM ET Corporate Participants Rohit Bhardwaj - Chief Financial Officer Scott Rook - President and Chief Executive Officer Conference Call Participants Steve Hansen - Raymond James Nelson Ng - RBC Capital Markets Gary Ho - Desjardins Joel Jackson - BMO Capital Markets Zachary Evershed - National Bank Financial Operator Good morning, ladies and gentlemen, and welcome to the Chemtrade Logistics Income Fund Q4 2024 Conference Call. At this time, all lines are in a listen-only mode.
Positive
Zacks Investment Research
1 month ago
Chemed Q4 Earnings & Revenues Top, Stock Climbs, Margins Contract
CHE's earnings and revenues beat estimates in the fourth quarter of 2024.
Neutral
Seeking Alpha
1 month ago
Chemed Corporation (CHE) Q4 2024 Earnings Call Transcript
Chemed Corporation (NYSE:CHE ) Q4 2024 Earnings Conference Call February 27, 2025 10:00 AM ET Company Participants Holley Schmidt – Assistant Controller Kevin McNamara – President and Chief Executive Officer Mike Witzeman – Chief Financial Officer Nick Westfall – Chairman and Chief Executive Officer, Chemed VITAS Healthcare Corporation Conference Call Participants Michael Murray – RBC Capital Markets Christian Porter – Bank of America Operator Hello, and welcome to the Chemed Corporation Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Positive
Zacks Investment Research
1 month ago
Chemed (CHE) Surpasses Q4 Earnings and Revenue Estimates
Chemed (CHE) came out with quarterly earnings of $6.83 per share, beating the Zacks Consensus Estimate of $6.79 per share. This compares to earnings of $6.60 per share a year ago.
Neutral
Business Wire
1 month ago
Chemed Reports Fourth-Quarter 2024 Results
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2024, versus the comparable prior-year period. Changes to Non-GAAP Metrics Chemed uses certain non-GAAP metrics such as EBITDA, adjusted.
Charts implemented using Lightweight Charts™